Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385442251> ?p ?o ?g. }
- W4385442251 endingPage "1420" @default.
- W4385442251 startingPage "1411" @default.
- W4385442251 abstract "Ovarian serous borderline tumors (SBT) are typically unilateral and are primarily treated using hysterectomy and bilateral salpingooophorectomy (SO). However, most young patients prefer fertility-sparing surgeries (FSS) with tumorectomy or unilateral SO. Micropapillary morphology and invasive implants have been designated as histopathological risk indicators for recurrence or metastasis, but their clinical impact remains controversial because of limitations like diagnostic inconsistency and incomplete surgical staging.A nationwide multi-institutional population-based retrospective surveillance was conducted with a thorough central pathology review to reveal the clinical features of SBT. Of 313 SBT patients enrolled in the Japanese Society of Clinical Oncology's Surveillance of Gynecologic Rare Tumors, 289 patient records were reviewed for clinical outcomes. The glass slides of patients at stage II-IV or with recurrence or death were re-evaluated by three gynecological pathologists.The 10-year overall and progression-free survival (PFS) rates were 98.6% and 92.3%. The median recurrence period was 40 months and 77.0% was observed in the contralateral ovary within 60 months. Patients aged ≤ 35 years underwent FSS more frequently and relapsed more (p < .001). A clinic-pathological analysis revealed diagnosis during pregnancy, FSS, and treatment at non-university institutes as well as advanced stage and large diameter were independent risk factors of recurrence. Among patients having pathologically confirmed SBTs, PFS was not influenced by the presence of micropapillary pattern or invasive implants.The recurrence rate was lower in this cohort than previous reports, but the clinical impacts of incomplete resection and misclassification of the tumor were still significant on the treatment of SBT." @default.
- W4385442251 created "2023-08-02" @default.
- W4385442251 creator A5004955803 @default.
- W4385442251 creator A5010897098 @default.
- W4385442251 creator A5015145175 @default.
- W4385442251 creator A5023191265 @default.
- W4385442251 creator A5025489625 @default.
- W4385442251 creator A5036589972 @default.
- W4385442251 creator A5037991551 @default.
- W4385442251 creator A5046191363 @default.
- W4385442251 creator A5059466654 @default.
- W4385442251 creator A5063042904 @default.
- W4385442251 creator A5071439913 @default.
- W4385442251 creator A5073332474 @default.
- W4385442251 creator A5087351447 @default.
- W4385442251 creator A5087677239 @default.
- W4385442251 creator A5090361588 @default.
- W4385442251 date "2023-08-01" @default.
- W4385442251 modified "2023-10-02" @default.
- W4385442251 title "Ovarian serous borderline tumors with recurrent or extraovarian lesions: a Japanese, retrospective, multi-institutional, population-based study" @default.
- W4385442251 cites W1966010019 @default.
- W4385442251 cites W1974156227 @default.
- W4385442251 cites W1986818451 @default.
- W4385442251 cites W1988519585 @default.
- W4385442251 cites W2008126982 @default.
- W4385442251 cites W2020107445 @default.
- W4385442251 cites W2071605994 @default.
- W4385442251 cites W2108808116 @default.
- W4385442251 cites W2143737296 @default.
- W4385442251 cites W2149122549 @default.
- W4385442251 cites W2408988026 @default.
- W4385442251 cites W2594045061 @default.
- W4385442251 cites W2803368721 @default.
- W4385442251 cites W2947615633 @default.
- W4385442251 cites W2963452953 @default.
- W4385442251 cites W3005918809 @default.
- W4385442251 cites W3006908171 @default.
- W4385442251 doi "https://doi.org/10.1007/s10147-023-02393-z" @default.
- W4385442251 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37526805" @default.
- W4385442251 hasPublicationYear "2023" @default.
- W4385442251 type Work @default.
- W4385442251 citedByCount "0" @default.
- W4385442251 crossrefType "journal-article" @default.
- W4385442251 hasAuthorship W4385442251A5004955803 @default.
- W4385442251 hasAuthorship W4385442251A5010897098 @default.
- W4385442251 hasAuthorship W4385442251A5015145175 @default.
- W4385442251 hasAuthorship W4385442251A5023191265 @default.
- W4385442251 hasAuthorship W4385442251A5025489625 @default.
- W4385442251 hasAuthorship W4385442251A5036589972 @default.
- W4385442251 hasAuthorship W4385442251A5037991551 @default.
- W4385442251 hasAuthorship W4385442251A5046191363 @default.
- W4385442251 hasAuthorship W4385442251A5059466654 @default.
- W4385442251 hasAuthorship W4385442251A5063042904 @default.
- W4385442251 hasAuthorship W4385442251A5071439913 @default.
- W4385442251 hasAuthorship W4385442251A5073332474 @default.
- W4385442251 hasAuthorship W4385442251A5087351447 @default.
- W4385442251 hasAuthorship W4385442251A5087677239 @default.
- W4385442251 hasAuthorship W4385442251A5090361588 @default.
- W4385442251 hasBestOaLocation W43854422512 @default.
- W4385442251 hasConcept C121608353 @default.
- W4385442251 hasConcept C126322002 @default.
- W4385442251 hasConcept C126838900 @default.
- W4385442251 hasConcept C141071460 @default.
- W4385442251 hasConcept C146357865 @default.
- W4385442251 hasConcept C150173356 @default.
- W4385442251 hasConcept C151730666 @default.
- W4385442251 hasConcept C167135981 @default.
- W4385442251 hasConcept C207886595 @default.
- W4385442251 hasConcept C2779494336 @default.
- W4385442251 hasConcept C2780084626 @default.
- W4385442251 hasConcept C2780140570 @default.
- W4385442251 hasConcept C2780427987 @default.
- W4385442251 hasConcept C2780435969 @default.
- W4385442251 hasConcept C2908647359 @default.
- W4385442251 hasConcept C71924100 @default.
- W4385442251 hasConcept C86803240 @default.
- W4385442251 hasConcept C99454951 @default.
- W4385442251 hasConceptScore W4385442251C121608353 @default.
- W4385442251 hasConceptScore W4385442251C126322002 @default.
- W4385442251 hasConceptScore W4385442251C126838900 @default.
- W4385442251 hasConceptScore W4385442251C141071460 @default.
- W4385442251 hasConceptScore W4385442251C146357865 @default.
- W4385442251 hasConceptScore W4385442251C150173356 @default.
- W4385442251 hasConceptScore W4385442251C151730666 @default.
- W4385442251 hasConceptScore W4385442251C167135981 @default.
- W4385442251 hasConceptScore W4385442251C207886595 @default.
- W4385442251 hasConceptScore W4385442251C2779494336 @default.
- W4385442251 hasConceptScore W4385442251C2780084626 @default.
- W4385442251 hasConceptScore W4385442251C2780140570 @default.
- W4385442251 hasConceptScore W4385442251C2780427987 @default.
- W4385442251 hasConceptScore W4385442251C2780435969 @default.
- W4385442251 hasConceptScore W4385442251C2908647359 @default.
- W4385442251 hasConceptScore W4385442251C71924100 @default.
- W4385442251 hasConceptScore W4385442251C86803240 @default.
- W4385442251 hasConceptScore W4385442251C99454951 @default.
- W4385442251 hasFunder F4320331467 @default.
- W4385442251 hasIssue "10" @default.
- W4385442251 hasLocation W43854422511 @default.